Form 4: Century Therapeutics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Brent Pfeiffenberger, President and CEO and a Director of Century Therapeutics, Inc., reported a transaction in 13,850 shares of common stock on September 11, 2026.
Summary
- Tax/exercise-price withholding: disposed of 13,850 Common Stock at $1.94 ($26,869) on September 11, 2026; holds 3,633,839 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Brent Pfeiffenberger — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Tax/exercise-price withholding | Common Stock | 13,850 | $2 | $26.9K | 3,633,839 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Tax/exercise-price withholding (13,850 shares) |
Keywords
insider transaction, Form 4, IPSC, Century Therapeutics, Inc., neutral, Brent Pfeiffenberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.